Atlas Trials

SEDPARK2: Post Marketing Surveillance to Observe Safety and Efficacy of Piribedil in Parkinson's Disease (PIR-002/K)

Clinical trial NCT00727727 · COMPLETED

Trial details

NCT number
NCT00727727
Sponsor
Desitin Arzneimittel GmbH
Status
COMPLETED
Study type
OBSERVATIONAL
Parkinson's Disease
Start date
2008-03-01
Primary completion
2008-12-01
Enrollment
750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.